The Latest Breaking News from CMS

Leqembi could become the first treatment of its kind to receive traditional approval from the FDA.

Among people age 65 and older, just 44% use tablets and only 61% have smartphones, according to Pew Research Center.

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Georgia is the latest state to enact a law that allows hospitals to create independent police forces. Critics worry the law enforcement focus could have unintended consequences.

Whether Medicare will or won’t cover certain health care costs may now depend on whether you are in Traditional Medicare or a private insurer’s Medicare Advantage plan.

Medicare drug price negotiations: Early signs have emerged of how these key talks will be handled.

While there is no known cure for Alzheimer’s disease, there are promising — but expensive — treatments.

Plus: The "Kids Online Safety Act" is back and as bad as ever, expect another interest rate hike today, and more…

A groundbreaking investigation has found two hospitals put a pregnant woman's life in jeopardy and violated the law by refusing to provide an emergency abortion when she went into premature labor at 17 weeks